InVita Healthcare Technologies, a leading provider of specialized software for complex medical, forensics, and community care environments, announced the release of Implant360 1.1, the latest evolution of the flagship platform. Implant360 provides a comprehensive 360o view of implant and explant inventory performance across departments, facilities, and enterprises, helping healthcare organizations control costs, reduce waste, and streamline the management of tissue and non-biologic medical devices, product recalls, and warranty claim reimbursements. With the 1.1 release, the platform now delivers its predictive capabilities and actionable insights directly to decision-makers’ inboxes through automated email alerts and scheduled reports, enabling faster and more proactive responses to inventory challenges.
Managing the complexity and volume of high-value, highly regulated inventory often presents challenges that leads to inefficiencies and financial loss, due to expiration loss, stockouts, and shortages. Implant360 tracks these critical metrics, sets thresholds, and flags at-risk inventory by product or location before it impacts operations. Whether predicting stockouts or shortages, balancing inventory between facilities, or preventing waste from expired inventory, Implant360 empowers management teams with actionable insights to reduce costs and ensure consistent patient care.
Implant360 1.1 builds on these strengths by delivering critical insights and performance analytic reporting directly to decision-makers inboxes, reducing the time between identifying issues and taking action. Automated email alerts notify users the moment thresholds, such as stockouts or impending expirations are reached. These alerts eliminate the need to log into the platform for updates. For potential stockouts, the system sends an alert and identifies surplus inventory at nearby locations, enabling resources sharing and inventory balancing between sister facilities to prevent unnecessary costs and ensure uninterrupted patient care. Scheduled analytic reports are delivered to stakeholders’ inboxes on a monthly or quarterly basis in preferred formats such as Excel or PDF, removing the need for manual report generation and distribution. This ensures management teams always have the latest insights to benchmark performance, monitor trends, and make informed, strategic decisions for optimal tissue and non-biologic inventory management by department, facility or across an enterprise.
“We are excited to provide healthcare management teams with greater convenience through these innovative enhancements,” said Todd Collins, President and CEO of InVita. “By automating the delivery of critical performance insights to decision-makers inboxes, the 1.1 release enables faster action and intervention to prevent costly operational disruptions.”
Implant360 continues to set the standard for proactive, data-driven tissue and implant inventory management, empowering clinical, supply chain, and materials management teams with the tools needed to reduce waste, control costs, and streamline operations.
Learn more about Implant360 and its innovative capabilities.
